rdf:type |
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0085862,
umls-concept:C0208804,
umls-concept:C0220901,
umls-concept:C0332257,
umls-concept:C0334094,
umls-concept:C0334463,
umls-concept:C0441655,
umls-concept:C0449560,
umls-concept:C0549193,
umls-concept:C0918012,
umls-concept:C1261473,
umls-concept:C1299583,
umls-concept:C1514923,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C2603343
|
pubmed:issue |
6
|
pubmed:dateCreated |
1998-9-16
|
pubmed:abstractText |
To evaluate the prognostic value of tumour proliferative activity, p53 accumulation and bcl-2 expression in a retrospective series of 216 patients with soft tissue sarcomas (STS).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0309-0167
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
536-46
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9675593-Adolescent,
pubmed-meshheading:9675593-Adult,
pubmed-meshheading:9675593-Aged,
pubmed-meshheading:9675593-Aged, 80 and over,
pubmed-meshheading:9675593-Antigens, Nuclear,
pubmed-meshheading:9675593-Cell Division,
pubmed-meshheading:9675593-Child,
pubmed-meshheading:9675593-Child, Preschool,
pubmed-meshheading:9675593-Follow-Up Studies,
pubmed-meshheading:9675593-Humans,
pubmed-meshheading:9675593-Immunohistochemistry,
pubmed-meshheading:9675593-Infant,
pubmed-meshheading:9675593-Ki-67 Antigen,
pubmed-meshheading:9675593-Middle Aged,
pubmed-meshheading:9675593-Nuclear Proteins,
pubmed-meshheading:9675593-Prognosis,
pubmed-meshheading:9675593-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:9675593-Retrospective Studies,
pubmed-meshheading:9675593-Sarcoma,
pubmed-meshheading:9675593-Soft Tissue Neoplasms,
pubmed-meshheading:9675593-Survival Rate,
pubmed-meshheading:9675593-Tumor Suppressor Protein p53
|
pubmed:year |
1998
|
pubmed:articleTitle |
Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
|
pubmed:affiliation |
Centre for Bone and Soft Tissue Sarcomas, University Hospital of Aarhus, Denmark.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|